the invention belongs to the field of oncology, and to the use of (s) - n - (3,4 - \u0434\u0438\u0444\u0442\u043e\u0440 - 2 - (2 - fluoride - 4 - \u0439\u043e\u0434\u0444\u0435\u043d\u0438\u043b\u0430\u043c\u0438\u043d\u043e) - 6 - \u043c\u0435\u0442\u043e\u043a\u0441\u0438\u0444\u0435\u043d\u0438\u043b) - 1 - (2)3 - \u0434\u0438\u0433\u0438\u0434\u0440\u043e\u043a\u0441\u0438\u043f\u0440\u043e\u043f\u0438\u043b) cyclopropane - 1 - \u0441\u0443\u043b\u044c\u0444\u043e\u043d\u0430\u043c\u0438\u0434\u0430 or \u0444\u0430\u0440\u043c\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438 acceptable salt or n - (4 - (2 - fluoride - 4 - \u0439\u043e\u0434\u0444\u0435\u043d\u0438\u043b\u0430\u043c\u0438\u043d\u043e) - 1.5 - dimethyl - 6 - jsoc - 16 - \u0434\u0438\u0433\u0438\u0434\u0440\u043e\u043f\u0438\u0440\u0438\u0434\u0438\u043d - 3 - yl) \u0446\u0438\u043a\u043b\u043e\u043f\u0440\u043e\u043f\u0430\u043d\u0441\u0443\u043b\u044c\u0444\u043e\u043d\u0430\u043c\u0438\u0434\u0430 or shape shifter thing, or it \u0444\u0430\u0440\u043c\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438 acceptable salts and pharmaceutical compositions that contain them.for the preparation of pharmaceutical treatment for pancreatic cancer.in addition, the present invention provides a means of connection \u0440\u0430\u0441\u043a\u0440\u044b\u0442\u043e\u0433\u043e in this application, the individual who needs it, by the introduction of ( s) - n - (3,4 - \u0434\u0438\u0444\u0442\u043e\u0440 - 2 - (2 - fluoride - 4 - \u0439\u043e\u0434\u0444\u0435\u043d\u0438\u043b\u0430\u043c\u0438\u043d\u043e) - 6 - \u043c\u0435\u0442\u043e\u043a\u0441\u0438\u0444\u0435\u043d\u0438\u043b) - 1 - (2,3 - \u0434\u0438\u0433\u0438\u0434\u0440\u043e\u043a\u0441\u0438\u043f\u0440\u043e\u043f\u0438\u043b) cyclopropane - 1 - \u0441\u0443\u043b\u044c\u0444\u043e\u043d\u0430\u043c\u0438\u0434\u0430 or \u0444\u0430\u0440\u043c\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438 acce
